CCDC170
Summary: The function of this gene and its encoded protein is not known. Several genome-wide association studies have implicated the region around this gene to be involved in breast cancer and bone mineral density, but no link to this specific gene has been found. [provided by RefSeq, May 2010].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
coiled-coil domain containing 170 | Ensembl:ENSG00000120262 | HGNC:HGNC:21177 | PA134876442 | 6q25.1 |
Gene expression in normal tissue: CCDC170
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CCDC170
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD329 | Merck60 | 3 |
iGMDRD269 | Purmorphamine | 1 |
iGMDRD103 | SN-38 | 3 |
iGMDRD202 | Curcumin | 5 |
iGMDRD5 | Tyrphostin AG 1478 | 3 |
iGMDRD434 | BMS-536924 | 3 |
iGMDRD77 | Itraconazole | 5 |
iGMDRD351 | GW843682X | 3 |
iGMDRD211 | (1S,3R)-RSL3 | 2 |
iGMDRD123 | Isoevodiamine | 3 |
iGMDRD84 | Lovastatin acid | 1 |
iGMDRD607 | Ubistatin B | 3 |
iGMDRD584 | VER 155008 | 3 |
iGMDRD248 | BRD4354 | 1 |
iGMDRD150 | RITA | 2 |
iGMDRD345 | Compound 10b [PMID: 11504634] | 1 |
iGMDRD701 | NVP-AUY922 | 6 |
iGMDRD730 | Kahalalide F | 3 |
iGMDRD399 | Selumetinib | 2 |
iGMDRD577 | BIX01294 | 3 |
iGMDRD60 | Quinoclamine | 3 |
iGMDRD369 | TGX-115 | 2 |
iGMDRD356 | PNU-74654 | 3 |
iGMDRD513 | BML-259 | 1 |
iGMDRD294 | Batimastat | 1 |
iGMDRD316 | N9-Isopropyl-olomoucine | 3 |
iGMDRD639 | YK 4-279 | 3 |
iGMDRD193 | Fqi1 | 1 |
iGMDRD163 | all trans Retinoic Acid | 3 |
iGMDRD126 | Tipifarnib | 6 |
iGMDRD433 | Lexibulin | 3 |
iGMDRD210 | AC55649 | 3 |
iGMDRD670 | ML 210 | 2 |
iGMDRD494 | Neopeltolide | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CCDC170